+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Real World Evidence Solution Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
Real World Evidence Solution Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type- Product Image
New

Real World Evidence Solution Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • PDF Icon

    Report

  • 116 Pages
  • August 2025
  • Region: Global
  • Prof Research
  • ID: 5832557
Description Jump to:
Real World Evidence (RWE) solutions encompass comprehensive platforms and services that collect, analyze, and interpret health data from real-world settings outside of traditional randomized controlled trials, including electronic health records, insurance claims, patient registries, and mobile health devices. These solutions enable healthcare stakeholders to understand treatment effectiveness, safety profiles, and patient outcomes in actual clinical practice environments. The market includes both data collection and management services as well as curated datasets from diverse healthcare sources. RWE solutions support regulatory decision-making, clinical development, market access strategies, and post-market surveillance across pharmaceutical, biotechnology, medical device, and healthcare payer organizations. The industry is driven by regulatory acceptance of real-world evidence, increasing healthcare costs pressures, personalized medicine advancement, and the growing availability of digital health data sources.

Market Size and Growth Forecast

The global real world evidence solutions market is projected to reach between USD 2.0 billion and USD 4.0 billion in 2025, with a compound annual growth rate (CAGR) of 13% to 19% through 2030, reflecting the increasing reliance on real-world data for healthcare decision-making and regulatory approvals.

Application Analysis

Healthcare Companies: Expected growth of 14.0-20.0%, driven by pharmaceutical and biotechnology companies seeking to demonstrate product value and optimize clinical development strategies. Trends focus on regulatory submission support and comparative effectiveness research.

Healthcare Payers: Projected growth of 12.0-18.0%, encompassing insurance companies and government payers using RWE for coverage decisions and cost-effectiveness evaluations. Developments emphasize population health management and outcomes-based contracting.

Healthcare Providers: Anticipated growth of 11.0-16.0%, including hospitals and health systems leveraging RWE for quality improvement, clinical decision support, and population health initiatives. Innovations prioritize integration with electronic health record systems.

Other Applications: Expected growth of 13.0-19.0%, covering medical device companies, regulatory agencies, and academic research institutions utilizing RWE for various healthcare applications.

Type Analysis

Services: Expected growth of 14.0-20.0%, encompassing data collection, analysis, regulatory consulting, and study design services. Trends emphasize specialized therapeutic area expertise and regulatory guidance support.

Data Sets: Projected growth of 12.0-18.0%, including curated healthcare databases, patient registries, and claims data repositories. Advances highlight data quality standardization and interoperability improvements.

Key Market Players

Leading companies include IQVIA, providing comprehensive real-world evidence solutions with extensive global data assets; Syneos Health, offering integrated clinical and commercial insights; Parexel International Corporation, specializing in regulatory and consulting services; Optum, leveraging extensive healthcare data and analytics capabilities; ICON, providing clinical research and real-world evidence services; Tata Consultancy Services, delivering technology-enabled healthcare analytics; Oracle, offering cloud-based healthcare data platforms; SAS Institute, providing advanced analytics and statistical software; Aetion, focusing on real-world evidence analytics platforms; and FLATIRON HEALTH, specializing in oncology real-world data and analytics.

Porter's Five Forces Analysis

Threat of New Entrants: Low to Moderate, due to significant data acquisition costs, regulatory expertise requirements, and established client relationships, though technology companies may enter through partnerships or acquisitions.

Threat of Substitutes: Low, as traditional clinical trials cannot fully replace real-world evidence for understanding treatment effectiveness in routine practice settings.

Bargaining Power of Buyers: Moderate, with large pharmaceutical companies having negotiating power while smaller biotech firms may have limited alternatives for specialized RWE capabilities.

Bargaining Power of Suppliers: Moderate, as healthcare data providers and technology platforms maintain some leverage due to data uniqueness and quality requirements.

Competitive Rivalry: High, with established players competing on data assets, analytical capabilities, regulatory expertise, and therapeutic area specialization while expanding service offerings.

Market Opportunities and Challenges

Opportunities: Increasing regulatory acceptance of real-world evidence creates new market opportunities for drug approvals and label expansions. Value-based healthcare initiatives drive demand for outcomes measurement and cost-effectiveness analysis. Digital health technology proliferation generates new data sources and analytical possibilities. Global expansion of healthcare systems increases addressable data sources and market reach. Artificial intelligence integration enables more sophisticated analytical capabilities.

Challenges: Data quality and standardization issues across different healthcare systems complicate analysis and interpretation. Privacy regulations regarding patient data require substantial compliance investments. Integration complexity across multiple data sources demands significant technical expertise. Regulatory uncertainty regarding RWE acceptance may limit investment decisions. Skills shortage in healthcare data science limits market growth potential.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter 4 Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Real World Evidence Solution Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Real World Evidence Solution Market in North America (2020-2030)
8.1 Real World Evidence Solution Market Size
8.2 Real World Evidence Solution Market by End Use
8.3 Competition by Players/Suppliers
8.4 Real World Evidence Solution Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Real World Evidence Solution Market in South America (2020-2030)
9.1 Real World Evidence Solution Market Size
9.2 Real World Evidence Solution Market by End Use
9.3 Competition by Players/Suppliers
9.4 Real World Evidence Solution Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Real World Evidence Solution Market in Asia & Pacific (2020-2030)
10.1 Real World Evidence Solution Market Size
10.2 Real World Evidence Solution Market by End Use
10.3 Competition by Players/Suppliers
10.4 Real World Evidence Solution Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Real World Evidence Solution Market in Europe (2020-2030)
11.1 Real World Evidence Solution Market Size
11.2 Real World Evidence Solution Market by End Use
11.3 Competition by Players/Suppliers
11.4 Real World Evidence Solution Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Real World Evidence Solution Market in MEA (2020-2030)
12.1 Real World Evidence Solution Market Size
12.2 Real World Evidence Solution Market by End Use
12.3 Competition by Players/Suppliers
12.4 Real World Evidence Solution Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Real World Evidence Solution Market (2020-2025)
13.1 Real World Evidence Solution Market Size
13.2 Real World Evidence Solution Market by End Use
13.3 Competition by Players/Suppliers
13.4 Real World Evidence Solution Market Size by Type
Chapter 14 Global Real World Evidence Solution Market Forecast (2025-2030)
14.1 Real World Evidence Solution Market Size Forecast
14.2 Real World Evidence Solution Application Forecast
14.3 Competition by Players/Suppliers
14.4 Real World Evidence Solution Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Merative
15.1.1 Company Profile
15.1.2 Main Business and Real World Evidence Solution Information
15.1.3 SWOT Analysis of Merative
15.1.4 Merative Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.2 Syneos Health
15.2.1 Company Profile
15.2.2 Main Business and Real World Evidence Solution Information
15.2.3 SWOT Analysis of Syneos Health
15.2.4 Syneos Health Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.3 IQVlA
15.3.1 Company Profile
15.3.2 Main Business and Real World Evidence Solution Information
15.3.3 SWOT Analysis of IQVlA
15.3.4 IQVlA Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.4 Parexel International Corporation
15.4.1 Company Profile
15.4.2 Main Business and Real World Evidence Solution Information
15.4.3 SWOT Analysis of Parexel International Corporation
15.4.4 Parexel International Corporation Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.5 Optum
15.5.1 Company Profile
15.5.2 Main Business and Real World Evidence Solution Information
15.5.3 SWOT Analysis of Optum
15.5.4 Optum Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.6 ICON
15.6.1 Company Profile
15.6.2 Main Business and Real World Evidence Solution Information
15.6.3 SWOT Analysis of ICON
15.6.4 ICON Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.7 Tata Consultancy Services
15.7.1 Company Profile
15.7.2 Main Business and Real World Evidence Solution Information
15.7.3 SWOT Analysis of Tata Consultancy Services
15.7.4 Tata Consultancy Services Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.8 Elevance Health
15.8.1 Company Profile
15.8.2 Main Business and Real World Evidence Solution Information
15.8.3 SWOT Analysis of Elevance Health
15.8.4 Elevance Health Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.9 SAS Institute
15.9.1 Company Profile
15.9.2 Main Business and Real World Evidence Solution Information
15.9.3 SWOT Analysis of SAS Institute
15.9.4 SAS Institute Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.10 Aetion
15.10.1 Company Profile
15.10.2 Main Business and Real World Evidence Solution Information
15.10.3 SWOT Analysis of Aetion
15.10.4 Aetion Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.11 Oracle
15.11.1 Company Profile
15.11.2 Main Business and Real World Evidence Solution Information
15.11.3 SWOT Analysis of Oracle
15.11.4 Oracle Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.12 Trinity
15.12.1 Company Profile
15.12.2 Main Business and Real World Evidence Solution Information
15.12.3 SWOT Analysis of Trinity
15.12.4 Trinity Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.13 Cognizant Technology Solutions Corporation
15.13.1 Company Profile
15.13.2 Main Business and Real World Evidence Solution Information
15.13.3 SWOT Analysis of Cognizant Technology Solutions Corporation
15.13.4 Cognizant Technology Solutions Corporation Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.14 Trinetx
15.14.1 Company Profile
15.14.2 Main Business and Real World Evidence Solution Information
15.14.3 SWOT Analysis of Trinetx
15.14.4 Trinetx Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.15 Cegedim Health Data
15.15.1 Company Profile
15.15.2 Main Business and Real World Evidence Solution Information
15.15.3 SWOT Analysis of Cegedim Health Data
15.15.4 Cegedim Health Data Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.16 Medpace Holdings
15.16.1 Company Profile
15.16.2 Main Business and Real World Evidence Solution Information
15.16.3 SWOT Analysis of Medpace Holdings
15.16.4 Medpace Holdings Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.17 FLATIRON HEALTH
15.17.1 Company Profile
15.17.2 Main Business and Real World Evidence Solution Information
15.17.3 SWOT Analysis of FLATIRON HEALTH
15.17.4 FLATIRON HEALTH Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.18 Verantos
15.18.1 Company Profile
15.18.2 Main Business and Real World Evidence Solution Information
15.18.3 SWOT Analysis of Verantos
15.18.4 Verantos Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.19 Fortrea
15.19.1 Company Profile
15.19.2 Main Business and Real World Evidence Solution Information
15.19.3 SWOT Analysis of Fortrea
15.19.4 Fortrea Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
15.20 Medidata
15.20.1 Company Profile
15.20.2 Main Business and Real World Evidence Solution Information
15.20.3 SWOT Analysis of Medidata
15.20.4 Medidata Real World Evidence Solution Revenue, Gross Margin and Market Share (2020-2025)
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Real World Evidence Solution Report
Table Data Sources of Real World Evidence Solution Report
Table Major Assumptions of Real World Evidence Solution Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Real World Evidence Solution Picture
Table Real World Evidence Solution Classification
Table Real World Evidence Solution Applications
Table Drivers of Real World Evidence Solution Market
Table Restraints of Real World Evidence Solution Market
Table Opportunities of Real World Evidence Solution Market
Table Threats of Real World Evidence Solution Market
Table COVID-19 Impact For Real World Evidence Solution Market
Table Raw Materials Suppliers
Table Different Production Methods of Real World Evidence Solution
Table Cost Structure Analysis of Real World Evidence Solution
Table Key End Users
Table Latest News of Real World Evidence Solution Market
Table Merger and Acquisition
Table Planned/Future Project of Real World Evidence Solution Market
Table Policy of Real World Evidence Solution Market
Table 2020-2030 North America Real World Evidence Solution Market Size
Figure 2020-2030 North America Real World Evidence Solution Market Size and CAGR
Table 2020-2030 North America Real World Evidence Solution Market Size by Application
Table 2020-2025 North America Real World Evidence Solution Key Players Revenue
Table 2020-2025 North America Real World Evidence Solution Key Players Market Share
Table 2020-2030 North America Real World Evidence Solution Market Size by Type
Table 2020-2030 United States Real World Evidence Solution Market Size
Table 2020-2030 Canada Real World Evidence Solution Market Size
Table 2020-2030 Mexico Real World Evidence Solution Market Size
Table 2020-2030 South America Real World Evidence Solution Market Size
Figure 2020-2030 South America Real World Evidence Solution Market Size and CAGR
Table 2020-2030 South America Real World Evidence Solution Market Size by Application
Table 2020-2025 South America Real World Evidence Solution Key Players Revenue
Table 2020-2025 South America Real World Evidence Solution Key Players Market Share
Table 2020-2030 South America Real World Evidence Solution Market Size by Type
Table 2020-2030 Brazil Real World Evidence Solution Market Size
Table 2020-2030 Argentina Real World Evidence Solution Market Size
Table 2020-2030 Chile Real World Evidence Solution Market Size
Table 2020-2030 Peru Real World Evidence Solution Market Size
Table 2020-2030 Asia & Pacific Real World Evidence Solution Market Size
Figure 2020-2030 Asia & Pacific Real World Evidence Solution Market Size and CAGR
Table 2020-2030 Asia & Pacific Real World Evidence Solution Market Size by Application
Table 2020-2025 Asia & Pacific Real World Evidence Solution Key Players Revenue
Table 2020-2025 Asia & Pacific Real World Evidence Solution Key Players Market Share
Table 2020-2030 Asia & Pacific Real World Evidence Solution Market Size by Type
Table 2020-2030 China Real World Evidence Solution Market Size
Table 2020-2030 India Real World Evidence Solution Market Size
Table 2020-2030 Japan Real World Evidence Solution Market Size
Table 2020-2030 South Korea Real World Evidence Solution Market Size
Table 2020-2030 Southeast Asia Real World Evidence Solution Market Size
Table 2020-2030 Australia Real World Evidence Solution Market Size
Table 2020-2030 Europe Real World Evidence Solution Market Size
Figure 2020-2030 Europe Real World Evidence Solution Market Size and CAGR
Table 2020-2030 Europe Real World Evidence Solution Market Size by Application
Table 2020-2025 Europe Real World Evidence Solution Key Players Revenue
Table 2020-2025 Europe Real World Evidence Solution Key Players Market Share
Table 2020-2030 Europe Real World Evidence Solution Market Size by Type
Table 2020-2030 Germany Real World Evidence Solution Market Size
Table 2020-2030 France Real World Evidence Solution Market Size
Table 2020-2030 United Kingdom Real World Evidence Solution Market Size
Table 2020-2030 Italy Real World Evidence Solution Market Size
Table 2020-2030 Spain Real World Evidence Solution Market Size
Table 2020-2030 Belgium Real World Evidence Solution Market Size
Table 2020-2030 Netherlands Real World Evidence Solution Market Size
Table 2020-2030 Austria Real World Evidence Solution Market Size
Table 2020-2030 Poland Real World Evidence Solution Market Size
Table 2020-2030 Russia Real World Evidence Solution Market Size
Table 2020-2030 MEA Real World Evidence Solution Market Size
Figure 2020-2030 MEA Real World Evidence Solution Market Size and CAGR
Table 2020-2030 MEA Real World Evidence Solution Market Size by Application
Table 2020-2025 MEA Real World Evidence Solution Key Players Revenue
Table 2020-2025 MEA Real World Evidence Solution Key Players Market Share
Table 2020-2030 MEA Real World Evidence Solution Market Size by Type
Table 2020-2030 Egypt Real World Evidence Solution Market Size
Table 2020-2030 Israel Real World Evidence Solution Market Size
Table 2020-2030 South Africa Real World Evidence Solution Market Size
Table 2020-2030 Gulf Cooperation Council Countries Real World Evidence Solution Market Size
Table 2020-2030 Turkey Real World Evidence Solution Market Size
Table 2020-2025 Global Real World Evidence Solution Market Size by Region
Table 2020-2025 Global Real World Evidence Solution Market Size Share by Region
Table 2020-2025 Global Real World Evidence Solution Market Size by Application
Table 2020-2025 Global Real World Evidence Solution Market Share by Application
Table 2020-2025 Global Real World Evidence Solution Key Vendors Revenue
Figure 2020-2025 Global Real World Evidence Solution Market Size and Growth Rate
Table 2020-2025 Global Real World Evidence Solution Key Vendors Market Share
Table 2020-2025 Global Real World Evidence Solution Market Size by Type
Table 2020-2025 Global Real World Evidence Solution Market Share by Type
Table 2025-2030 Global Real World Evidence Solution Market Size by Region
Table 2025-2030 Global Real World Evidence Solution Market Size Share by Region
Table 2025-2030 Global Real World Evidence Solution Market Size by Application
Table 2025-2030 Global Real World Evidence Solution Market Share by Application
Table 2025-2030 Global Real World Evidence Solution Key Vendors Revenue
Figure 2025-2030 Global Real World Evidence Solution Market Size and Growth Rate
Table 2025-2030 Global Real World Evidence Solution Key Vendors Market Share
Table 2025-2030 Global Real World Evidence Solution Market Size by Type
Table 2025-2030 Real World Evidence Solution Global Market Share by Type

Companies Mentioned

  • Merative
  • Syneos Health
  • IQVlA
  • Parexel International Corporation
  • Optum
  • ICON
  • Tata Consultancy Services
  • Elevance Health
  • SAS Institute
  • Aetion
  • Oracle
  • Trinity
  • Cognizant Technology Solutions Corporation
  • Trinetx
  • Cegedim Health Data
  • Medpace Holdings
  • FLATIRON HEALTH
  • Verantos
  • Fortrea
  • Medidata

Related Topics

Related Reports

Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030 - Product Image

Real World Evidence Solutions Market by Component (Datasets (Claims, Clinical, Pharmacy, Genomics), Application (Drug/Device Development (Cancer, Cardio, Neuro), Reimbursement), End User (Pharma, Medtech, Payers, Provider), Region - Global Forecast to 2030

  • Report
  • 377 Pages
  • Global
From
Real World Evidence Solutions - Global Strategic Business Report - Product Image

Real World Evidence Solutions - Global Strategic Business Report

  • Report
  • 246 Pages
  • Global
From
Real-World Evidence Solutions Market Report by Component, Therapeutic Area, End User, and Region 2025-2033 - Product Image

Real-World Evidence Solutions Market Report by Component, Therapeutic Area, End User, and Region 2025-2033

  • Report
  • 135 Pages
  • Global
From
Real World Evidence Solution Market - Global Forecast 2025-2030 - Product Image

Real World Evidence Solution Market - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Real-world Evidence Solutions Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Image

Real-world Evidence Solutions Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.